Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
2.575
-0.375 (-12.71%)
At close: Dec 5, 2025, 4:00 PM EST
2.680
+0.105 (4.08%)
After-hours: Dec 5, 2025, 7:27 PM EST
Onconetix Revenue
Onconetix had revenue of $303.65K in the quarter ending September 30, 2025, a decrease of -25.37%. This brings the company's revenue in the last twelve months to $1.22M, down -34.58% year-over-year. In the year 2024, Onconetix had annual revenue of $2.52M with 4,217.31% growth.
Revenue (ttm)
$1.22M
Revenue Growth
-34.58%
P/S Ratio
1.20
Revenue / Employee
$244,750
Employees
5
Market Cap
4.02M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ONCO News
- 2 months ago - Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. - GlobeNewsWire
- 2 months ago - Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement - GlobeNewsWire
- 2 months ago - Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM - GlobeNewsWire
- 5 months ago - Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement - GlobeNewsWire
- 6 months ago - Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel - GlobeNewsWire
- 6 months ago - Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders - GlobeNewsWire
- 7 months ago - Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq - GlobeNewsWire
- 7 months ago - Onco-Innovations Uplists to Cboe Canada - Business Wire